Albany Molecular Research, Inc. Completes Acquisition of Great Lakes Chemical Corporation Facility
AMRI first announced the signing of a definitive agreement to purchase the facility on Friday, September 21, 2001. AMRI acquired the 88,000 square foot facility near Chicago, IL for $10 million in cash.
Albany Molecular Research, Inc. is a chemistry-based drug discovery and development company, focusing on applications for new small molecule prescription drugs. The company conducts R&D projects and collaborates with many leading pharmaceutical, biotechnology and genomics companies, and is developing new chemistry technology for potential prescription drug applications.
Most read news
Other news from the department business & finance
Get the chemical industry in your inbox
From now on, don't miss a thing: Our newsletter for the chemical industry, analytics, lab technology and process engineering brings you up to date every Tuesday and Thursday. The latest industry news, product highlights and innovations - compact and easy to understand in your inbox. Researched by us so you don't have to.